Challenger rejects takeover offer valuing it at A$8.17 billion

TAL Daiichi Life Australia offered A$12.2 a share for the roughly 79.5% of Challenger it does not own, but the board said the price did not adequately represent fair value.
In this article
Challenger rejected a revised takeover proposal on 19 November that valued the Australian investment manager at A$8.17 billion (about $5.5 billion). Its board said the price did not adequately represent fair value for shareholders in a transaction for control.
TAL Daiichi Life Australia offered A$12.20 per share for the roughly 79.5% of Challenger it does not already own, a 2.1% premium to Challenger’s previous closing price. It followed an earlier non-binding proposal of A$11.8 per share and talks between the companies. The revised proposal was non-binding and conditional, and Challenger told shareholders they did not need to take action.
The companies and the earlier offer
Challenger provides retirement income products, including annuities, and manages investments for individual and institutional clients. TAL is an Australian subsidiary of Japanese insurer Daiichi Life Group and owns 20.47% of Challenger, LSEG data cited by Reuters showed.
TAL’s earlier non-binding proposal offered A$11.80 per share for the remaining shares through a scheme of arrangement. The revised price was 40 Australian cents higher. Challenger had described the companies' engagement in an October 26 update. At its recent annual meeting, the company said it would continue to engage with TAL for a better price.
Accordingly, the board finds it appropriate to engage with TAL Daiichi Life to determine whether a proposal can be reached that could be recommended to shareholders.
Shares fall after rejection
Challenger shares fell as much as 2.7% to A$11.63 in early Sydney trading. They were last reported down 2.1%, compared with a 0.8% fall in the broader market.
Cameron Curko, chief investment officer at Pitcher Partners Sydney, said he believed Challenger’s board would be open to a deal, but that a higher premium would be needed to start a formal process.
What comes next
For its earlier proposal, TAL said a transaction would be subject to satisfactory exclusive due diligence on Challenger’s business, agreement on final terms and required regulatory approvals, among other conditions. No binding agreement had been reached. Challenger said it would keep the market informed under its disclosure obligations.
Follow AveNews
Related articles
CompaniesDaiichi Life unit proposes takeover valuing Challenger at A$7.94 billion
The Japanese insurer's unit proposes paying A$11.80 a share for the rest of the Australian investment manager, with Challenger's board considering the conditional offer.
1 min
Sources
Show all 4 sourcesShow fewer
CNA BusinessChallenger says revised Daiichi Life takeover offer falls short, shares down (opens in a new tab)
- surestone.com.auChallenger Says $12.20 TDA Revised Offer Not Fair Value (opens in a new tab)
- tal.com.auTAL Daiichi Life Australia Pty Limited proposed acquisition of remaining shares in Challenger Limited | TAL (opens in a new tab)
- financialstandard.com.auChallenger rejects TAL's revised offer | Financial Standard (opens in a new tab)
